Episode 89: The Ethics of New Drug Approvals (Rebroadcast)

2 Docs Talk: The podcast about healthcare, the science of medicine and everything in between.

Content provided by Amy Rogers, Kendall Britt, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Amy Rogers, Kendall Britt, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

7y ago 12:31

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on March 09, 2023 00:56 (1+ y ago). Last successful fetch was on January 07, 2023 09:45 (1+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

The process of drug approval is long and expensive. To complicate matters, pharmaceutical companies, patients, an the FDA are all invested in the process, for different reasons – and they aren’t always the same.

Today we discuss the story of how a new drug came to market and the unusual circumstances around its approval.

Resources:

FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

CDC on Duchenne Muscular Dystrophy

Right to Try

Compassionate Use

Be sure and subscribe in iTunes or Stitcher if you haven’t already. And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

137 episodes

#Medicine #Evidencebasedmedicine #Healthcarepolicy #Fitness #Amy Rogers #Kendall Britt #Science #Health and Well-Being